Carolina del Norte

Quiénes somos

  • 23 de mayo de 2022
    Sotorasib y panitumumab frente a la elección del investigador para participantes con sarcoma de rata de Kirsten (KRAS) con mutación p.G12C (CodeBreak 300)
  • 5 de abril de 2022
    Evaluación de la inmunogenicidad de pING-hHER3FL
  • 5 de abril de 2022
    NT-I7 (Efineptakin Alfa) in Combination With Pembrolizumab in Participants With Advanced Solid Tumors
  • 5 de abril de 2022
    Pemigatinib for the Treatment of Metastatic or Unresectable Colorectal Cancer Harboring FGFR Alterations
  • 5 de abril de 2022
    Safety, Tolerability, and Immunogenicity of mRNA-4157 Alone in Participants With Resected Solid Tumors and in Combination With Pembrolizumab in Participants With Unresectable Solid Tumors
  • 5 de abril de 2022
    A Study of CC-95251, a Monoclonal Antibody Directed Against SIRPα, in Participants With Advanced Solid and Hematologic Cancers
  • 5 de abril de 2022
    Un estudio para evaluar MEDI5752 en sujetos con tumores sólidos avanzados
  • 5 de abril de 2022
    A Study of a Personalized Neoantigen Vaccine in Combination With Immune Checkpoint Blockade for Patients With Metastatic Colorectal Cancer
  • 5 de abril de 2022
    INNATE: Immunotherapy During Neoadjuvant Therapy for Rectal Cancer
  • 5 de abril de 2022
    Estudio de la plataforma TAPISTRY (Tumor-Agnostic Precision Immuno-Oncology and Somatic Targeting Rational for You)